华厦眼科(301267)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

301267 华厦眼科

已收盘 04-30 15:00:00

{"stockData":{"symbol":"301267","market":"SZ","secType":"STK","nameCN":"华厦眼科","latestPrice":18.19,"timestamp":1777532601000,"preClose":18.19,"halted":0,"volume":5144950,"delay":0,"changeRate":0,"floatShares":648000000,"shares":840000000,"eps":0.5508,"marketStatus":"已收盘","change":0,"latestTime":"04-30 15:00:00","open":18.25,"high":18.49,"low":18.1,"amount":94243800,"amplitude":0.0214,"askPrice":18.2,"askSize":62,"bidPrice":18.19,"bidSize":139,"shortable":0,"etf":0,"ttmEps":0.5508,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1778031000000},"marketStatusCode":5,"adr":0,"adjPreClose":18.19,"symbolType":"stock","openAndCloseTimeList":[[1777512600000,1777519800000],[1777525200000,1777532400000]],"highLimit":20.01,"lowLimit":16.37,"ibTradeSell":false,"ibTradeBuySell":false,"totalEquity":840000000,"isCdr":false,"pbRate":2.81,"roa":"--","peRate":33.024691,"roe":"3.15%","epsLYR":0.53,"committee":0.170897,"marketValue":15280000000,"turnoverRate":0.0079,"status":2,"floatMarketCap":11795000000},"requestUrl":"/m/hq/s/301267","defaultTab":"news","newsList":[{"id":"2631666510","title":"东吴证券：给予华厦眼科买入评级","url":"https://stock-news.laohu8.com/highlight/detail?id=2631666510","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2631666510?lang=zh_cn&edition=full","pubTime":"2026-04-29 21:43","pubTimestamp":1777470182,"startTime":"0","endTime":"0","summary":"东吴证券股份有限公司朱国广,冉胜男,苏丰近期对华厦眼科进行研究并发布了研究报告《2025年报&2026年一季度点评：26Q1业绩回暖，屈光业务引领增长》，给予华厦眼科买入评级。2025年，公司通过非同一控制下企业合并新增了北京华厦民众眼科医院、宁波鄞州华厦眼科诊所、杭州临平华厦视光诊所等机构，持续扩大服务网络。最新盈利预测明细如下：该股最近90天内共有1家机构给出评级，买入评级1家；过去90天内机构目标均价为23.87。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026042900066929.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301267","601555"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2631545565","title":"华厦眼科2025年平稳双增、2026Q1盈利提速：技术+区域协同构筑长期护城河","url":"https://stock-news.laohu8.com/highlight/detail?id=2631545565","media":"中金财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2631545565?lang=zh_cn&edition=full","pubTime":"2026-04-29 10:57","pubTimestamp":1777431429,"startTime":"0","endTime":"0","summary":"中国网财经4月29日讯 4月27日晚间，华厦眼科 同步披露2025年年报与2026年一季报。数据显示，2025年公司实现营业收入41.39亿元，同比增长2.78%；归母净利润4.41亿元，同比增长2.80%。迈入2026年一季度，经营质量进一步改善，当期实现营收11.50亿元，同比增长5.22%；归母净利润1.72亿元，同比增长14.69%，利润增速大幅跑赢营收增速。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://sc.stock.cnfol.com/ggzixun/20260429/32188038.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"zhongjincaijing_highlight","symbols":["BK0236","301267"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2630949311","title":"图解华厦眼科年报：第四季度单季净利润同比下降9.91%","url":"https://stock-news.laohu8.com/highlight/detail?id=2630949311","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2630949311?lang=zh_cn&edition=full","pubTime":"2026-04-28 02:18","pubTimestamp":1777313917,"startTime":"0","endTime":"0","summary":"证券之星消息，华厦眼科2025年年报显示，当年度公司主营收入41.39亿元，同比上升2.79%；归母净利润4.41亿元，同比上升2.8%；扣非净利润4.25亿元，同比上升4.07%；其中2025年第四季度，公司单季度主营收入8.67亿元，同比上升2.63%；单季度归母净利润700.81万元，同比下降9.91%；单季度扣非净利润199.06万元，同比上升125.59%；负债率27.83%，投资收益4659.74万元，财务费用4748.28万元，毛利率43.31%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026042800006274.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301267"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2627449910","title":"华厦眼科：持续与多家保险公司开展深度沟通和合作","url":"https://stock-news.laohu8.com/highlight/detail?id=2627449910","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2627449910?lang=zh_cn&edition=full","pubTime":"2026-04-14 20:52","pubTimestamp":1776171139,"startTime":"0","endTime":"0","summary":"证券之星消息，华厦眼科04月13日在投资者关系平台上答复投资者关心的问题。目前，公司正沿着“医险协同、服务患者”的方向稳步推进各项工作。首先是持续与多家保险公司开展深度沟通和合作；其次在理赔服务升级上，我们已联合部分保险公司落地快赔、直赔服务。再次感谢您对华厦眼科的支持！","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026041400036393.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0236","301267"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2622025009","title":"华厦眼科：截至目前公司未收到进一步通知","url":"https://stock-news.laohu8.com/highlight/detail?id=2622025009","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2622025009?lang=zh_cn&edition=full","pubTime":"2026-03-25 16:36","pubTimestamp":1774427776,"startTime":"0","endTime":"0","summary":"证券之星消息，华厦眼科03月25日在投资者关系平台上答复投资者关心的问题。请问目前案件处于何种司法阶段？请明确回复相关情况，感谢华厦眼科回复：尊敬的投资者您好，感谢您对华厦眼科的关注。关于董事长的最新情况，截至目前公司未收到进一步通知。如有相关进展，公司定将严格按照相关法律法规的规定及时履行信息披露义务。再次感谢您对华厦眼科的支持！","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026032500030899.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301267","BK0236"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2620446285","title":"华厦眼科：积极推进眼科医疗服务创新与智慧医疗体系建设","url":"https://stock-news.laohu8.com/highlight/detail?id=2620446285","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2620446285?lang=zh_cn&edition=full","pubTime":"2026-03-17 15:07","pubTimestamp":1773731237,"startTime":"0","endTime":"0","summary":"证券之星消息，华厦眼科03月17日在投资者关系平台上答复投资者关心的问题。未来是否会拓展智慧眼科新场景？公司始终关注并积极推进眼科医疗服务创新与智慧医疗体系建设，为患者提供优质、多元化的诊疗服务。目前相关应用尚在逐步探索和落地中，对公司业绩不构成重大影响，敬请投资者注意投资风险。再次感谢您对华厦眼科的支持！","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026031700020426.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0236","301267"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2617509637","title":"华厦眼科：公司将积极谋求战略新突破","url":"https://stock-news.laohu8.com/highlight/detail?id=2617509637","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2617509637?lang=zh_cn&edition=full","pubTime":"2026-03-06 11:33","pubTimestamp":1772767985,"startTime":"0","endTime":"0","summary":"证券之星消息，华厦眼科03月05日在投资者关系平台上答复投资者关心的问题。公司始终密切关注资本市场动态，高度重视股东权益。再次感谢您对华厦眼科的支持！","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026030600015559.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301267","BK0236"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2603603126","title":"华厦眼科（301267）披露董事会换届选举结果，1月15日股价上涨0.05%","url":"https://stock-news.laohu8.com/highlight/detail?id=2603603126","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2603603126?lang=zh_cn&edition=full","pubTime":"2026-01-15 17:40","pubTimestamp":1768470044,"startTime":"0","endTime":"0","summary":"截至2026年1月15日收盘，华厦眼科报收于19.39元，较前一交易日上涨0.05%，最新总市值为162.88亿元。该股当日开盘19.25元，最高19.58元，最低19.18元，成交额达1.15亿元，换手率为0.92%。近日，华厦眼科医院集团股份有限公司发布2026年第一次临时股东会决议公告，公司于2026年1月14日召开2026年第一次临时股东会，审议通过董事会换届选举议案。表决结果均获高票通过，中小股东参与积极。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026011500029324.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0236","301267"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2601053100","title":"华厦眼科：全飞秒SMILE pro手术量突破6,000例","url":"https://stock-news.laohu8.com/highlight/detail?id=2601053100","media":"证券之星","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2601053100?lang=zh_cn&edition=full","pubTime":"2026-01-05 15:21","pubTimestamp":1767597680,"startTime":"0","endTime":"0","summary":"今年5月，公司下属厦门眼科中心、郑州华厦视光眼科医院、成都爱迪眼科医院等5家医院，作为全国首批眼科医疗机构，率先引进蔡司新一代机器人全飞秒VISUMAX 800手术设备及全飞秒SMILE pro手术技术。截至12月6日，上述首批引进设备开展的全飞秒SMILE pro手术量已突破6,000例。其中，厦门眼科中心是全国首家全飞秒SMILE pro手术量突破1000例的医院，也是全球最短时间突破2000例的单体医院。再次感谢您对华厦眼科的支持！","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026010500015145.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0236","301267"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2595276625","title":"股市必读：华厦眼科（301267）12月26日董秘有最新回复","url":"https://stock-news.laohu8.com/highlight/detail?id=2595276625","media":"证券之星","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2595276625?lang=zh_cn&edition=full","pubTime":"2025-12-29 03:29","pubTimestamp":1766950150,"startTime":"0","endTime":"0","summary":"截至2025年12月26日收盘，华厦眼科报收于18.21元，下跌0.49%，换手率0.52%，成交量3.34万手，成交额6088.66万元。2025年，公司制订并披露了《未来三年股东分红回报规划》，12月22日实施了中期利润分配，进一步加强股东回报。再次感谢您对华厦眼科的支持！当日关注点来自交易信息汇总：12月26日主力资金净流出374.33万元，散户资金净流入456.29万元。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025122900001240.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0236","301267"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2594299853","title":"华厦眼科：累计分红约5.07亿元","url":"https://stock-news.laohu8.com/highlight/detail?id=2594299853","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2594299853?lang=zh_cn&edition=full","pubTime":"2025-12-26 20:52","pubTimestamp":1766753536,"startTime":"0","endTime":"0","summary":"证券之星消息，华厦眼科12月26日在投资者关系平台上答复投资者关心的问题。上市以来公司每年都实施现金分红，截止目前已累计分红约5.07亿元。此外，2024年公司积极实施股份回购，通过自有资金累计回购公司股份752.78万股，累计成交金额超2亿元。再次感谢您对华厦眼科的支持！","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025122600033311.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0236","301267"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2594791234","title":"华厦眼科：多措并举积极做好市值管理工作","url":"https://stock-news.laohu8.com/highlight/detail?id=2594791234","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2594791234?lang=zh_cn&edition=full","pubTime":"2025-12-25 20:52","pubTimestamp":1766667135,"startTime":"0","endTime":"0","summary":"证券之星消息，华厦眼科12月24日在投资者关系平台上答复投资者关心的问题。二级市场股价受多方面因素影响。尽管面临挑战，公司管理层始终高度重视市值管理与股东回报。未来，公司将继续专注提升经营质量与核心竞争力，并结合实际情况，多措并举积极做好市值管理工作。再次感谢您对华厦眼科的支持！","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025122500033410.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0236","301267"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2591672222","title":"华厦眼科：引进国际前沿诊疗新技术新设备","url":"https://stock-news.laohu8.com/highlight/detail?id=2591672222","media":"证券之星","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2591672222?lang=zh_cn&edition=full","pubTime":"2025-12-16 11:37","pubTimestamp":1765856233,"startTime":"0","endTime":"0","summary":"证券之星消息，华厦眼科12月16日在投资者关系平台上答复投资者关心的问题。作为国内大型眼科医疗连锁集团，华厦眼科始终秉持“精湛医术、合理收费、高尚医德，贴心服务，快捷方便，优雅环境”的经营理念，持续为患者提供专业、优质、收费合理的诊疗服务。再次感谢您对华厦眼科的支持！","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025121600015399.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301267","BK0236"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2591642389","title":"华厦眼科（301267）披露2025年中期分红派息实施公告，12月15日股价下跌0.97%","url":"https://stock-news.laohu8.com/highlight/detail?id=2591642389","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2591642389?lang=zh_cn&edition=full","pubTime":"2025-12-15 22:18","pubTimestamp":1765808302,"startTime":"0","endTime":"0","summary":"截至2025年12月15日收盘，华厦眼科报收于18.33元，较前一交易日下跌0.97%，最新总市值为153.97亿元。该股当日开盘18.39元，最高18.63元，最低18.29元，成交额达1.27亿元，换手率为1.06%。公司近日发布公告，披露2025年中期分红派息实施情况。根据公告，本次分红以公司总股本840,000,000股剔除回购股份7,527,840股后的832,472,160股为基数，向全体股东每10股派发现金红利0.90元（含税），合计派发74,922,494.40元。回购股份不参与分红，分配方案与董事会审议通过的一致。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025121500035530.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0236","301267"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2589897549","title":"华厦眼科：公司经营一切正常不存在退市风险","url":"https://stock-news.laohu8.com/highlight/detail?id=2589897549","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2589897549?lang=zh_cn&edition=full","pubTime":"2025-12-05 20:52","pubTimestamp":1764939145,"startTime":"0","endTime":"0","summary":"证券之星消息，华厦眼科12月05日在投资者关系平台上答复投资者关心的问题。最近公司股价一路下跌，前几天看到证券软件公布的消息，是在2025年12月15日后调出创业板指数。公司经营一切正常，已连续多年保持盈利，上市以来公司每年实施现金分红，且正在实施2025年中期分红，不存在触及退市风险警示及其他风险警示的有关情形。再次感谢您对华厦眼科的支持！","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025120500037038.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0236","301267"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2588884162","title":"华厦眼科：通过自建及并购推进全国布局","url":"https://stock-news.laohu8.com/highlight/detail?id=2588884162","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2588884162?lang=zh_cn&edition=full","pubTime":"2025-12-04 20:51","pubTimestamp":1764852696,"startTime":"0","endTime":"0","summary":"证券之星消息，华厦眼科(301267)12月03日在投资者关系平台上答复投资者关心的问题。投资者提问：董秘：您好！请问公司线下的实体店的盈利模式是加盟的合作方式还是直营。华厦眼科回复：尊敬的投资者您好，感谢您对华厦眼科的关注。公司长期专注于眼科医疗服务，已经建立了全国连锁运营的诊疗服务体系。公司正按照发展战略规划，通过自建及并购方式，稳步推进全国医疗服务网络布局。再次感谢您对华厦眼科的支持！以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025120400036925.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301267","BK0236"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2588087475","title":"华厦眼科：构建完善近视防控体系","url":"https://stock-news.laohu8.com/highlight/detail?id=2588087475","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2588087475?lang=zh_cn&edition=full","pubTime":"2025-12-02 15:12","pubTimestamp":1764659526,"startTime":"0","endTime":"0","summary":"证券之星消息，华厦眼科12月02日在投资者关系平台上答复投资者关心的问题。公司拥有由国际眼科科学院院士赵堪兴教授领衔的高水平专家团队，在儿童青少年常见及疑难眼病、儿童青少年近视防控领域具备丰富的临床经验。再次感谢您对华厦眼科的支持！","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025120200016984.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0236","301267"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2581383047","title":"华厦眼科（301267）3.2亿股限售股将于11月7日解禁，占总股本38.05%","url":"https://stock-news.laohu8.com/highlight/detail?id=2581383047","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2581383047?lang=zh_cn&edition=full","pubTime":"2025-11-07 08:05","pubTimestamp":1762473958,"startTime":"0","endTime":"0","summary":"证券之星消息，根据市场公开信息整理，华厦眼科于11月7日将有3.2亿股限售股份解禁，为公司首发原股东限售股份，占公司总股本38.05%。本次解禁后，公司还有1.92亿股限售股份，占总股本22.8%。华厦眼科主营业务：眼科医疗服务,向眼科疾病患者提供各种眼科疾病的诊断、治疗等眼科医疗服务,同时还向社会大众提供眼疾、近视预防干预工作。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025110700005656.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301267","BK0236"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2581082146","title":"华厦眼科：积极举办及参与国内外眼科学术交流活动","url":"https://stock-news.laohu8.com/highlight/detail?id=2581082146","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2581082146?lang=zh_cn&edition=full","pubTime":"2025-11-06 09:06","pubTimestamp":1762391174,"startTime":"0","endTime":"0","summary":"证券之星消息，华厦眼科11月05日在投资者关系平台上答复投资者关心的问题。与宝岛还有哪些交流华厦眼科回复：尊敬的投资者您好，感谢您对华厦眼科的关注。近年来，公司积极举办及参与国内外眼科学术交流活动，共同推进我国眼科临床诊疗技术、教学与科学研究发展。再次感谢您对华厦眼科的支持！","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025110600005963.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301267","BK0236"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2581779869","title":"华厦眼科（301267）披露首次公开发行前已发行股份解除限售并上市流通的提示性公告，11月05日股价上涨0.52%","url":"https://stock-news.laohu8.com/highlight/detail?id=2581779869","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2581779869?lang=zh_cn&edition=full","pubTime":"2025-11-05 22:39","pubTimestamp":1762353561,"startTime":"0","endTime":"0","summary":"公司近日发布关于首次公开发行前已发行股份解除限售并上市流通的提示性公告。本次解除限售股东为2户，分别为华厦医疗投资（厦门）有限公司和苏庆灿，解除限售股份数量合计511,170,000股，占公司总股本的60.8536%，限售期为公司股票上市之日起36个月。本次解除限售股份上市流通日为2025年11月7日。股东苏庆灿为公司董事长、总经理，其解除限售股份中实际可上市流通部分为其解除限售数量的25%，其余将转为高管锁定股。保荐机构对本次解除限售无异议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025110500040906.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301267","BK0236"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"ret":0,"serverTime":1777553023238,"stockEarnings":[{"period":"1week","weight":0.0496},{"period":"1month","weight":0.07},{"period":"3month","weight":-0.0355},{"period":"6month","weight":-0.0651},{"period":"1year","weight":0.0056},{"period":"ytd","weight":0.0117}],"compareEarnings":[{"period":"1week","weight":0.0003},{"period":"1month","weight":0.047},{"period":"3month","weight":-0.0121},{"period":"6month","weight":0.0386},{"period":"1year","weight":0.2498},{"period":"ytd","weight":0.0349}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"华厦眼科医院集团股份有限公司","boardCode":"AI0083","boardName":"卫生","stockholders":"21273人(较上一季度减少4.52%)","perCapita":"30482股","listingDate":"2022-11-07","address":"福建省厦门市湖里区五通西路999号之1701","registeredCapital":"84000万元","survey":"　　华厦眼科医院集团股份有限公司的主营业务是眼科专科医疗服务。公司的主要产品是白内障项目、眼后段项目、屈光项目、眼视光综合项目。","listedPrice":50.88},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.42.1","shortVersion":"4.42.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"华厦眼科(301267)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供华厦眼科(301267)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"华厦眼科,301267,华厦眼科股票,华厦眼科股票老虎,华厦眼科股票老虎国际,华厦眼科行情,华厦眼科股票行情,华厦眼科股价,华厦眼科股市,华厦眼科股票价格,华厦眼科股票交易,华厦眼科股票购买,华厦眼科股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"华厦眼科(301267)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供华厦眼科(301267)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}